News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amgen (AMGN)'s New JV Fulfills Promise to Emphasize China



5/15/2013 3:13:03 PM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

May 15, 2013 -- To date, Amgen, the US biotech drug company, has not had a major presence in China. In February of this year, Amgen said it would use a combination of partnerships and M&A to increase its participation in the China market. The first of these relationships is the Amgen-Zhejiang Beta JV, announced last week, which will promote and distribute Amgen’s colon cancer Vectibix. More details....

Stock Symbol: (NSDQ: AMGN)



Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES